GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (TSE:4534) » Definitions » Net Margin %

Mochida Pharmaceutical Co (TSE:4534) Net Margin % : 5.59% (As of Dec. 2023)


View and export this data going back to 1963. Start your Free Trial

What is Mochida Pharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Mochida Pharmaceutical Co's Net Income for the three months ended in Dec. 2023 was 円1,606 Mil. Mochida Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円28,742 Mil. Therefore, Mochida Pharmaceutical Co's net margin for the quarter that ended in Dec. 2023 was 5.59%.

The historical rank and industry rank for Mochida Pharmaceutical Co's Net Margin % or its related term are showing as below:

TSE:4534' s Net Margin % Range Over the Past 10 Years
Min: 3.01   Med: 8.55   Max: 10.53
Current: 3.01


TSE:4534's Net Margin % is ranked worse than
51.37% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.5 vs TSE:4534: 3.01

Mochida Pharmaceutical Co Net Margin % Historical Data

The historical data trend for Mochida Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co Net Margin % Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.69 4.52 8.34 9.59 6.44

Mochida Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.75 -6.55 6.82 4.65 5.59

Competitive Comparison of Mochida Pharmaceutical Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Net Margin % falls into.



Mochida Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Mochida Pharmaceutical Co's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=6649/103261
=6.44 %

Mochida Pharmaceutical Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=1606/28742
=5.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mochida Pharmaceutical Co  (TSE:4534) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Mochida Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mochida Pharmaceutical Co (TSE:4534) Business Description

Traded in Other Exchanges
N/A
Address
1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (TSE:4534) Headlines

No Headlines